HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)

Normal values appear to vary greatly by population

Loading...

Normal values appear to vary greatly by population

mg/dL
mIU/L

References

  1. Jong Han Choi. Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes.. Diabetes & metabolism journal, 2025
  2. NA. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).. Journal of hepatology, 2024
  3. Zezhi Ke. Long‐term insulin resistance is associated with frailty, frailty progression, and cardiovascular disease. Journal of Cachexia, Sarcopenia and Muscle, 2024
  4. J. Echouffo-Tcheugui. Diagnosis and Management of Prediabetes: A Review.. JAMA, 2023
  5. Jun-Hyuk Lee. Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023
  6. G. Ferrannini. Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.. Diabetes care, 2022
  7. Tiange Wang. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study. Diabetes Care, 2022
  8. S. Erqou. Insulin resistance and incident heart failure: a meta‐analysis. European Journal of Heart Failure, 2022
  9. José G González-González. HOMA-IR as a predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-analysis.. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2022
  10. D. Jonas. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.. JAMA, 2021
  11. Martin K Rutter. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.. Circulation, 2008
  12. E. Bonora. Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population. Diabetes Care, 2007
  13. Yiqing Song. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.. Diabetes care, 2007
  14. T. M. Wallace. Use and abuse of HOMA modeling.. Diabetes care, 2004
  15. A. Katsuki. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.. Diabetes care, 2001
  16. E. Bonora. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.. Diabetes care, 2000